Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)
NCT: NCT03918161 · COMPLETED
Brief Summary
: GREFFE\_ELASTO IRM will evaluate Magnetic Resonance Elastography (MRE) in renal transplant patients with suspected interstitial fibrosis/tubular atrophy lesions requiring biopsy graft sampling under ultrasound control. The main objective is to search a correlation between renal graft parenchymal elasticity values obtained in vivo by MRE, and the histological data of renal fibrosis by biopsy sampling, and providing a non-invasive tool capable of detecting and monitoring this development over time, making possible in the future to reduce the number of renal biopsies.
Frequently Asked Questions
What is Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)?
Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM) is a clinical trial registered under NCT03918161. Current status: COMPLETED.
What is the status of NCT03918161?
The current status of NCT03918161 (Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)) is: COMPLETED.
When did Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM) start?
Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM) started on 2019-07-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.